2022-04-04

NJBIZ Conversations: Chris Beddard

Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD

Chris Beddard is the Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD.

In this interview with NJBIZ, she speaks about the BD Onclarity™ HPV Assay, an HPV test with extended genotyping that holds the promise of improved outcomes. As long as women use it.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis
Vaginitis | News & Updates
Press release: New study finds up to one-third of women receive clinical misdiagnosis of vaginitis
Fast Company op-ed
Cervical Cancer | News & Updates
POV: The U.S. healthcare system is failing Black and Latina women
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Cervical Cancer | Webinars & Videos
ReachMD: Genotype specific persistence: Looking beyond HPV 16